This paper provides experienced insights for biopharmaceutical professionals who are interested in optimizing their ...

Renaissance will optimize the formulation of intranasal Foralumab and assist with scaling up production for clinical trials.

Chief Science Officer, Peter Surman, shares insight on why pharmaceutical companies should consider softgels for their next ...

Eisai will maintain the rights to tasurgratinib worldwide outside of the licensed regions.

The U.S. Food and Drug Administration (FDA) has approved Fapon Biopharma’s Investigational New Drug (IND) application for ...

Magnet Biomedicine, a biopharmaceutical company advancing molecular glue discovery, has entered a collaboration and license ...

International Process Plants (IPP), a leader in repurposing industrial manufacturing sites, has leased its fermentation-based ...

Beyond manufacturing capacity, sponsors seek expertise in specialized drug formulations, regulatory affairs, and service ...

Sygnature Discovery has appointed Kieron Hall as its new Chief Commercial Officer and Board member. Kieron will play a key ...

ProRx Pharma, a cGMP, 503B outsourcing facility focused on providing essential compounded medications, has expanded its ...

Aims to establish a qualification strategy for operating PAS-X MES in the AWS Cloud in compliance with regulatory ...

The U.S. Food and Drug Administration (FDA) has accepted Sobi’s supplemental Biologics License Application (sBLA) for ...